Working… Menu

Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01934634
Recruitment Status : Unknown
Verified November 2015 by US Oncology Research.
Recruitment status was:  Active, not recruiting
First Posted : September 4, 2013
Last Update Posted : November 10, 2015
Novartis Pharmaceuticals
Delta Clinical Research, LLC
Information provided by (Responsible Party):
US Oncology Research

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 2016
Study Completion Date : No date given